Federal Regulators Look To Stop Billion Dollar Deals Between Drug Companies, Generic BrandsFederal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for years, steep price declines that can top 90 percent.

More From CBS DC

CBSLocal App
Watch Live
Eat See Play

Listen Live